The acquisition allows IntrinsiQ to become a part of ION Solutions, a unit of AmerisourceBergen Specialty Group.
The combination of IntrinsiQ’s software applications and ION Solutions’ oncology technology platform will increase the company’s proprietary data offerings to both physicians and manufacturers.
IntrinsiQ’s IntelliDose software will augment ION Solutions’ existing clinical, practice management and reimbursement tools which aids oncologists to make correct clinical dosing decisions.
AmerisourceBergen Specialty Group President James Frary said the addition of IntrinsiQ’s informatics to ION Solutions’ tools and services demonstrates their commitment to provide superior value to community oncology.